<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="96647">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01846585</url>
  </required_header>
  <id_info>
    <org_study_id>23501</org_study_id>
    <secondary_id>R01NR013662-01</secondary_id>
    <nct_id>NCT01846585</nct_id>
  </id_info>
  <brief_title>Treatment for Insomnia During Pregnancy</brief_title>
  <official_title>The Effectiveness of Non-Pharmacological Treatment for Insomnia During Pregnancy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Nursing Research (NINR)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to improve sleep during pregnancy and the postpartum period in women
      who are experiencing insomnia, using a brief non-pharmacological treatment.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of insomnia remission</measure>
    <time_frame>Baseline to 30 weeks postpartum</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Insomnia severity</measure>
    <time_frame>Baseline to 30 weeks postpartum</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression severity</measure>
    <time_frame>Baseline to 30 weeks postpartum</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep Characteristics</measure>
    <time_frame>Baseline to 30 weeks postpartum</time_frame>
    <description>Self-report measures characterizing sleep onset latency (time to fall asleep), wake after sleep onset, sleep duration.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">184</enrollment>
  <condition>Sleep Initiation and Maintenance Disorders</condition>
  <arm_group>
    <arm_group_label>ABTI</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Arousal Based Therapy for Insomnia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CBTI</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Cognitive Behavioral Therapy for Insomnia</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Arousal Based Therapy for Insomnia</intervention_name>
    <description>Intervention includes education about sleep and a desensitization technique to reduce sleep interfering arousal</description>
    <arm_group_label>ABTI</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive Behavioral Therapy for Insomnia</intervention_name>
    <description>Intervention includes education about sleep and behavioral and cognitive strategies to improve sleep</description>
    <arm_group_label>CBTI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Meets Diagnostic and Statistical Manual (IV-TR edition) criteria for insomnia
             (duration criterion - 1 month)

          -  Pregnant with gestational age between 18-32 weeks.

          -  Adequately fluent in English or Spanish.

        Exclusion Criteria:

          -  Some co-morbid sleep disorders (e.g., moderate to severe obstructive sleep apnea)

          -  Co-morbid psychiatric disorder

          -  Use of medications, herbs or other drugs with known effects on sleep

          -  Unstable medical conditions

          -  Currently engaged in psychotherapy or other treatments for insomnia
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rachel Manber, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elizabeth Rangel, BSc</last_name>
    <phone>650-723-2641</phone>
    <email>erangel@stanford.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michelle Reade, BSc</last_name>
    <phone>650 725-0947</phone>
    <email>mreade@stanford.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Rangel, BSc</last_name>
      <phone>650-723-2641</phone>
      <email>erangel@stanford.edu</email>
    </contact>
    <contact_backup>
      <last_name>Michelle Reade, BSc</last_name>
      <phone>650 725-0947</phone>
      <email>mreade@stanford.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Rachel Manber, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <lastchanged_date>November 1, 2016</lastchanged_date>
  <firstreceived_date>April 30, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Rachel Manber</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
